Bio Essence Corporation

BIOE

US09090C1053

Pharmaceuticals

Delayed OTC Markets Other stock markets 01:22:14 2024-01-23 pm EST			5-day change	1st Jan Change
0.26 ^USD	-49.02%		-.--%	-49.02%

Apr. 15	Bio Essence Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Apr. 04	Health Up, Inc acquired Bio Essence Herbal Essentials, Inc. from Bio Essence Corporation on for $0.4 million	CI

Bio Essence Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022

May 16, 2022 at 01:25 pm EDT

Bio Essence Corporation reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was USD 0.181579 million compared to USD 0.212028 million a year ago. Revenue was USD 0.306414 million compared to USD 0.212028 million a year ago. Net loss was USD 0.23312 million compared to USD 0.210355 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.

Latest news about Bio Essence Corporation

Bio Essence Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 15	CI
Health Up, Inc acquired Bio Essence Herbal Essentials, Inc. from Bio Essence Corporation on for $0.4 million	Apr. 03	CI
Newways, Inc. completed the acquisition of Bio Essence Pharmaceutical, Inc. from Bio Essence Corporation.	Dec. 30	CI
Bio Essence Corporation Announces Resignation of Sharon Mair from the Board of Directors	Dec. 13	CI
Newways, Inc. agreed to acquire Bio Essence Pharmaceutical, Inc. from Bio Essence Corporation for $0.3 million.	Dec. 12	CI
Bio Essence Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Bio Essence Corporation Appoints William E. Sluss as Chief Financial Officer	23-09-07	CI
Bio Essence Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Bio Essence Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
Bio Essence Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
Bio Essence Corporation Auditor Raises 'Going Concern' Doubt	23-03-29	CI
Bio Essence Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Bio Essence Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15	CI
Bio Essence Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
Bio Essence Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-31	CI
Bio Essence Corporation Auditor Raises 'Going Concern' Doubt	22-03-30	CI

Chart Bio Essence Corporation

Duration

Period

More charts

Company Profile

Bio Essence Corp. (Bio Essence) is an herbal health, diet, and nutrition company. The Company provides herbal health, diet, and vitamin nutritional supplements through three operational subsidiaries, namely Bio Essence Pharmaceutical, Inc. (BEP) that helps to serves as a health supplement original equipment manufacturer (OEM) service; Bio Essence Herbal Essentials Inc. (BEH), which provides products and service through practitioners' market, and McBE Pharma, Inc. (McBE), which focuses on developing, manufacturing, and sales prescription drugs. Bio Essence Herbal Essentials Inc. targets healthcare practitioners with herbal products in the form of granules, capsules, pills, and tablets. The Company also offers special formulation service to practitioners. Bio Essence provides customers direct connections with integrative healthcare practitioners, such as dietitians, nutraceutical practitioners, and other practitioners.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
BIO ESSENCE CORPORATION	-49.02%	9.88M
NOVO NORDISK A/S	+24.17%	562B
JOHNSON & JOHNSON	-6.55%	358B
MERCK & CO., INC.	+19.27%	322B
ABBVIE INC.	+8.01%	297B
ASTRAZENECA PLC	+13.45%	219B
NOVARTIS AG	+6.04%	199B
ROCHE HOLDING AG	-10.51%	196B
PFIZER, INC.	-11.65%	149B
AMGEN INC.	-6.83%	146B